TrialThe Lancet. Infectious diseases2018

Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial.

Faustino Torrico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.